the aid library

LIST OPTIONS

Filter

8456

Primary Surgery Vol. One: Non-Trauma
recommended

Cotton, M., et al. Global Healp; Deutsche Gesellschaft für Tropenchirurgie; International Coll. Essential Surgery (2016) CC

This comprehensive book has established itself as the most useful text for the medical practitioner in poor-resource settings who is obliged to manage surgical cases. It is particularly adapted for those whose surgical experience is basic or minimal. Importantly, it has extensive advice about pitfal... more

Download (5662)

View PDF (16771)

MSF Clinical Guidelines. Diagnosis and Treatment Manual
recommended

Médecins sans Frontières (MSF) (2022) C2

This diagnostic and treatment manual is designed for use by medical professionals involved in curative care at the dispensary and hospital levels. We have tried to respond in the simplest and most practical way possible to the questions and problems faced by field medical staff, using the accumulate... more

Download (589)

View PDF (790)

Interim National Guidelines for Monkeypox Outbreak Response

Federal Ministry of Health - Nigeria Centre for Disease Contro (2017) C2

This document provides information and recommendations for action, based on the current available knowledge around monkeypox. It is a first draft which will be updated in light of evolving evidence and additional information as they become available.

Download (326)

View PDF (374)

Rwanda: HEALTH SECTOR ANNUAL REPORT July 2014-June 2015

Ministry of Health, Rwanda (2015) C2

For the Fiscal Year 2014-2015, the Health Sector continued to implement interventions and strategies meant to improve the availability, accessibility and utilization of quality healthcare services across public and private health facilities; and to ensure the reduction of the burden of communicable ... more

Download (255)

View PDF (250)

WHO policy brief: COVID-19 testing, 14 September 2022

World Health Organization WHO (2022) C_WHO

The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises. It remains critical for national programmes to continue to offer testing for COVI... more

Download (526)

View PDF (1239)

Clinical Protocol for the Health & Development of Adolescent and Young people in Nigeria

Federal Ministry of Health, Nigeria; WHO; UNFPA (2011) C_WHO

Download (565)

View PDF (821)

HIV Prevalence and Associated Risk Factors: Analysis of Change Over Time in Mainland Tanzania

Mmbaga, Elia John ICF International (2013) C2

DHS Working Papers No. 85

Download (488)

View PDF (1460)

Haiti: Cholera figures (18 November 2016)

UN Office for the Coordination of Humanitarian Affairs (2016) C1

This document summarizes Haiti's cholera situation as of November 16, 2016. Between January and October 2016, Haiti reported 35,203 new suspected cholera cases (32% increase from 2015) and 369 deaths (56% increase). After Hurricane Matthew, cases rose dramatically, with 52% of new cases concentrated... more

Download (242)

View PDF (450)

Mpox Molecular Diagnostic Tests(RT-PCR)

Africa Center for Disease Control and Prevention (2024) CC

On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public ... more

Download (437)

View PDF (660)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (277)

View PDF (582)

Epidemic transition metrics - Global

Unaids; AIDSinfo (2019) C2

Accessed: 17.11.2019

Download (274)

View PDF (265)

Epidemic transition metrics

UNAIDS; AIDSinfo (2019) C2

Sources: National Commitment and Policy Instrument, 2019

Download (1143)

View PDF (2212)

Global Action Plan for Prevention and Control of Pneumonia (GAPP)

World Health Organization; UNICEF (2008)

Download (189)

View PDF (373)

Iran's daily COVID-19 deaths hit record high of 655

Hafezi, P. Reuters (2021) C1

16 August 2021

Download (1160)

View PDF (2951)

Management of pneumonia in community settings
recommended

World Health Organization (2004)

Download (1026)

View PDF (1664)

Revised WHO classification and treatment of childhood pneumonia at health facilities

World Health Organization (2014)

The revised guidelines present two major changes to existing guidelines: (A) there are now just 2 categories of pneumonia instead of 3 (“pneumonia” which is treated at home with oral amoxicillin and “severe pneumonia” which requires injectable antibiotics) and (B) oral amoxicillin replaces o... more

Download (124)

View PDF (105)

Technical note on accelerating P. falciparum elimination in the Americas

Pan American Health Organization (PAHO) (2023) C_WHO

All malaria-endemic countries in the Region of the Americas have taken on the challenge of eliminating malaria and have focused their health programs and strategies on that goal. The risk of emergence of artemisinin resistance in the Americas, the characteristics of P. falciparum parasite, and the e... more

External Link

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

Jara A., Undurraga E. A. et al (2021) C2

Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome c... more

Download (1110)

View PDF (1312)

A framework for malaria elimination

World Health Organization WHO (2017) C_WHO

The document provides guidance on the tools, activities and strategies required to achieve malaria elimination and prevent re-establishment of transmission in countries, regardless of where they lie across the spectrum of transmission intensity. It is intended to inform national malaria elimination ... more

Primary Surgery Vol. One: Non-Trauma recommended

MSF Clinical Guidelines. Diagnosis and Treatment Manual recommended

Management of pneumonia in community settings recommended

Primary Surgery Vol. One: Non-Trauma
recommended

MSF Clinical Guidelines. Diagnosis and Treatment Manual
recommended

Management of pneumonia in community settings
recommended